Folate Bioavailability and Health

2002 ◽  
Vol 72 (1) ◽  
pp. 46-52 ◽  
Author(s):  
Anne M. Molloy

The vitamin folate has been largely responsible for a fundamental shift in our perception of the role of vitamins in maintaining health. Ten years ago, two independent clinical trials showed that supplementing a woman’s diet with folic acid before and during early pregnancy reduced the prevalence of neural tube defects (NTDs) by more than 70%. A remarkable aspect was that folic acid supplementation was not correcting a clinical deficiency in most of these women. It was later shown that the risk of having an NTD-affected birth was negatively associated with maternal red cell folate status, and the level of risk varied throughout the normal range, suggesting an interaction of genetic factors with folate nutritional status. It now appears that an insufficient folate status might contribute to risk of developing a variety of medical conditions throughout an individual’s lifetime, from certain congenital malformations and poor pregnancy outcomes to cardiovascular disease, some malignancies, and neurological dysfunction of the elderly. Thus, an alternative view of folate nutrition has emerged. This view goes beyond the idea of a dietary requirement to prevent signs and symptoms of clinical deficiency towards one of achieving an optimal status to reduce risk of certain chronic diseases, and includes the concept that an individual’s genetic make-up may substantially affect the vitamin status that they can achieve without supplements or fortification.

2019 ◽  
Vol 18 (1) ◽  
pp. 50-59 ◽  
Author(s):  
Aneta Myszczyszyn ◽  
Rafał Krajewski ◽  
Monika Ostapów ◽  
Lidia Hirnle

AbstractIntroduction. Folic acid is a compound classified as B group vitamins. In the body it is subject to processes that transfer its inactive form into a form responsible for biological effects of folic acid, i.e. 5-methyltetrahydrofolate (5-MTHF). It is, in particular, responsible for processes of the correct biosynthesis of purine and pyridine bases present in the formation of DNA and RNA molecules. Humans do not synthesize the endogenous form of folic acid; therefore, it is vital to supplement this vitamin in its natural form or multivitamin preparations. The most folic acid is found in the green leafy vegetables (spinach, peas, asparagus) and in offal (liver). An adequate supply of folic acid is especially indicated in pregnant women with a reduced amount of folic acid due to its use by an intensively developing foetus. The recommended dose of folic acid during this period is 0.4 mg/24h and this dose varies depending on the patient’s and her family’s medical history. The updated state of knowledge on the role of vitamin B9 in the body has been presented. The importance of its supplementation in specific clinical cases was analyzed.Summary. Many studies indicate an important role of the folic acid in the prevention of congenital defects of the nervous, cardiovascular and urogenital systems. Its deficiency increases the risk of complications in pregnancy, such as recurrent miscarriages, pre-eclampsia or postpartum haemorrhage. For this reason, a prophylactic folic acid supplementation is recommended, in women with increased risk of its deficiency, in particular.


2011 ◽  
Vol 31 (4) ◽  
pp. 500-506 ◽  
Author(s):  
Amy J. Hewitt ◽  
Amber L. Knuff ◽  
Matthew J. Jefkins ◽  
Christine P. Collier ◽  
James N. Reynolds ◽  
...  

2021 ◽  
pp. 1-25
Author(s):  
Lucía Iglesias-Vázquez ◽  
Núria Serrat ◽  
Cristina Bedmar ◽  
Meritxell Pallejà-Millán ◽  
Victoria Arija

Abstract This research evaluates the prevalence of inadequate folate status in early pregnancy, the pattern of prenatal folic acid (FA) supplementation and associated factors in Spanish pregnant women from the ECLIPSES study, which included 791 participants prior gestational week 12. A cross-sectional evaluation of red blood cell (RBC) folate levels was performed at recruitment and used to calculate the prevalence of folate deficiency (RBC folate<340 nmol/L) and insufficiency (RBC folate<906 nmol/L). Sociodemographic and lifestyle data, as well as information on prenatal FA supplementation were recorded. Descriptive and multivariate statistical analyses were performed. The prevalence of folate deficiency and insufficiency were 9.6% and 86.5%, respectively. Most of women used prenatal FA supplements but only 6.3% did so as recommended. Supplementation with FA during the periconceptional period abolished folate deficiency and reduced folate insufficiency. Prenatal folic acid supplementation with ≥1000 µg/d in periconceptional time and pregnancy planning increased RBC folate levels. The main risk factor for folate insufficiency in early pregnancy were getting prenatal FA supplementation out of the periconceptional time (OR 3.32, 95%CI 1.02–15.36), while for folate deficiency they were young age (OR 2.02, 95%CI 1.05–3.99), and smoking (OR 2.39, 95%CI 1.30–4.37). In addition, social and ethnic differences according to folate status were also identified. As conclusion, periconceptional FA use is crucial for achieving optimal folate levels in early pregnancy. Pregnancy planning should focus on young women, smokers, those with low consumption of folate-rich foods, low socioeconomic status or from ethnic minorities.


2013 ◽  
Vol 27 (S1) ◽  
Author(s):  
Ligi Paul ◽  
Cristina Razzari ◽  
Francesca Sampietro ◽  
Gessica Fontana ◽  
Isabella Fermo ◽  
...  

2003 ◽  
Vol 62 (3) ◽  
pp. 591-598 ◽  
Author(s):  
Paul M. Finglas ◽  
Anthony J. A. Wright ◽  
Caroline A. Wolfe ◽  
David J. Hart ◽  
Dawn M. Wright ◽  
...  

The purpose of the present paper is to review our current understanding of the chemistry and biochemistry of folic acid and related folates, and to discuss their impact on public health beyond that already established in relation to neural-tube defects. Our understanding of the fascinating world of folates and C1metabolism, and their role in health and disease, has come a long way since the discovery of the B-vitamin folic acid by Wills (1931), and its first isolation by Mitchellet al. (1941). However, there is still much to do in perfecting methods for the measurement of folate bioavailability, and status, with a high extent of precision and accuracy. Currently, examination of the relationships between common gene polymorphisms involved in C1metabolism and folate bioavailability and folate status, morbidity, mortality and longevity is evaluated as a series of individual associations. However, in the future, examination of the concurrent effects of such common gene polymorphisms may be more beneficial.


Author(s):  
Lilianne Abramsson-Zetterberg ◽  
Louise J.K. Durling ◽  
Fan Yang-Wallentin ◽  
Elisabet Rytter ◽  
Bengt Vessby

Sign in / Sign up

Export Citation Format

Share Document